31 – 40 of 46
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines.
(
- Contribution to journal › Article
-
Mark
Activation of TAFI on the Surface of Streptococcus pyogenes Evokes Inflammatory Reactions by Modulating the Kallikrein/Kinin System
(
- Contribution to journal › Article
-
Mark
Treatment of invasive streptococcal infection with a peptide derived from human high molecular weight kininogen.
(
- Contribution to journal › Article
-
Mark
SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation.
(
- Contribution to journal › Article
-
Mark
A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
C1q Inhibits Immune Complex-Induced Interferon-alpha Production in Plasmacytoid Dendritic Cells A Novel Link Between C1q Deficiency and Systemic Lupus Erythematosus Pathogenesis
(
- Contribution to journal › Article
- 2008
-
Mark
The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes.
(
- Contribution to journal › Article
-
Mark
Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation.
(
- Contribution to journal › Article
-
Mark
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
(
- Contribution to journal › Article
- 2007
-
Mark
The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids
(
- Contribution to journal › Article